Phase I/II Trials of Silymarin for Chronic Liver Diseases Data Coordinating Cente

水飞蓟素治疗慢性肝病的I/II期试验数据协调中心

基本信息

  • 批准号:
    7123231
  • 负责人:
  • 金额:
    $ 35.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-15 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A consortium including 4 clinical sites, a data coordinating center, and project scientists and medical officers from the National Center for Complementary and Alternative Medicine (NCCAM) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is being formed as a cooperative agreement to design and implement three phase l/ll trials of silymarin for patients with liver disease. Although silymarin has been used to treat liver disease for hundreds of years, there has not been rigorous research to indicate that such therapy is safe or efficacious. There is a potential role for silymarin, particularly for treating patients with chronic hepatitis C virus who have contraindications to therapy with interferon and ribavirin. The current lack of therapy for non-alcoholic steatohepatitis provides silymarin with a potential role in treating patients with this condition. Our proposed DCC will bring together expertise in biostatistics; pharmacodynamics and pharmacokinetics, particularly of silymarin; hepatology; epidemiology; data management; and computer systems to assist the consortium with designing and implementing multiple studies. Working in collaboration with the clinical sites and NIH scientists and personnel, the DCC will provide the consortium with assistance in: 1. Study design, implementation, and management of approximately three multi-center phase l/ll clinical trials. 2. Developing research databases containing information about approximately 480 participants recruited at 4 clinical sites to address safety and efficacy of silymarin for treating patients with liver disease. 3. Provide clinical, methodological, data management, and statistical expertise to design the studies, accurately computerize the data, monitor study operations and patient safety, analyze the data, and report the results. 4. Provide administrative support to the Steering Committee, subcommittees of the Steering Committee, NIH project scientists and medical officers, and Data and Safety Monitoring Board.
描述(由申请人提供):一个包括4个临床研究中心、一个数据协调中心、以及来自国家补充和替代医学中心(NCCAM)和国家糖尿病、消化和肾脏疾病研究所(NIDDK)的项目科学家和医疗官员的联盟正在形成,作为一项合作协议,设计和实施针对肝病患者的水飞蓟素的三个I/II期试验。虽然水飞蓟素已被用于治疗肝脏疾病数百年,但还没有严格的研究表明这种疗法是安全或有效的。水飞蓟素具有潜在的作用,特别是用于治疗有干扰素和利巴韦林治疗禁忌症的慢性丙型肝炎病毒患者。目前缺乏对非酒精性脂肪性肝炎的治疗,这为水飞蓟素提供了治疗这种疾病的潜在作用。 我们提议的DCC将汇集生物统计学方面的专业知识;药效学和药代动力学,特别是水飞蓟素;肝病学;流行病学;数据管理;和计算机系统,以协助该财团设计和实施多项研究。DCC将与临床研究中心和NIH科学家和工作人员合作,在以下方面为联盟提供帮助: 1.约三项多中心I/II期临床试验的研究设计、实施和管理。 2.开发研究数据库,其中包含在4个临床站点招募的约480名参与者的信息,以解决水飞蓟素治疗肝病患者的安全性和有效性。 3.提供临床、方法学、数据管理和统计专业知识,以设计研究、准确计算数据、监测研究操作和患者安全、分析数据并报告结果。 4.为指导委员会、指导委员会的小组委员会、NIH项目科学家和医疗官员以及数据和安全监测委员会提供行政支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven H. Belle其他文献

Su1336: TREATMENT INITIATION AND OUTCOMES OF AFRICAN AMERICANS AND NON-AFRICAN AMERICANS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION
  • DOI:
    10.1016/s0016-5085(22)63528-5
  • 发表时间:
    2022-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mohamed Hassan;Kelsey R. Leonard;Marc G. Ghany;Mandana Khalili;Lewis R. Roberts;Richard K. Sterling;Steven H. Belle;Anna Lok
  • 通讯作者:
    Anna Lok
AH-07: Physical activity levels of patients undergoing bariatric surgery in the longitudinal assessment of bariatric surgery (LABS) study
  • DOI:
    10.1016/j.soard.2008.03.025
  • 发表时间:
    2008-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Wendy C. King;Steven H. Belle;William H. Chapman;Anita P. Courcoulas;Gregory Dakin;George M. Eid;David R. Flum;William B. Inabnet;James Mitchell;Brant Oelschlager;Emma J. Patterson;Bruce M. Wolfe
  • 通讯作者:
    Bruce M. Wolfe
Familial influences on breast parenchymal patterns
家族对乳腺实质模式的影响
  • DOI:
  • 发表时间:
    1980
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    J. Wolfe;S. Albert;Steven H. Belle;M. Salane
  • 通讯作者:
    M. Salane
P-69 Explaining the volume outcome relationship in bariatric surgery
  • DOI:
    10.1016/j.soard.2011.04.071
  • 发表时间:
    2011-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mark D. Smith;Abdus Wahed;Bruce M. Wolfe;Emma J. Patterson;Steven H. Belle;Anita P. Courcoulas;Surebh Khandelwal;David R. Flum;James E. Mitchell;Alfons Pomp;Walter J. Pories
  • 通讯作者:
    Walter J. Pories
Report from the Pitt-UNOS Liver Transplant Registry.
来自 Pitt-UNOS 肝移植登记处的报告。
  • DOI:
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    0.9
  • 作者:
    Steven H. Belle;K. Detre
  • 通讯作者:
    K. Detre

Steven H. Belle的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven H. Belle', 18)}}的其他基金

The Physiology of the Weight Reduced State Data Coordinating Center
减肥的生理学状态数据协调中心
  • 批准号:
    10395562
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
The Physiology of the Weight Reduced State Data Coordinating Center
减肥的生理学状态数据协调中心
  • 批准号:
    10188159
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
The Physiology of the Weight Reduced State Data Coordinating Center
减肥的生理学状态数据协调中心
  • 批准号:
    10612227
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
The Physiology of the Weight Reduced State Data Coordinating Center
减肥的生理学状态数据协调中心
  • 批准号:
    10618137
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
Data Management and Statistical Core
数据管理与统计核心
  • 批准号:
    10410383
  • 财政年份:
    2020
  • 资助金额:
    $ 35.7万
  • 项目类别:
Data Management and Statistical Core
数据管理与统计核心
  • 批准号:
    10590699
  • 财政年份:
    2020
  • 资助金额:
    $ 35.7万
  • 项目类别:
Data Management and Statistical Core
数据管理与统计核心
  • 批准号:
    10161688
  • 财政年份:
    2020
  • 资助金额:
    $ 35.7万
  • 项目类别:
Cross-study analysis of coordinated randomized clinical trials for weight managem
体重管理协调随机临床试验的交叉研究分析
  • 批准号:
    8969694
  • 财政年份:
    2014
  • 资助金额:
    $ 35.7万
  • 项目类别:
Cross-study analysis of coordinated randomized clinical trials for weight managem
体重管理协调随机临床试验的交叉研究分析
  • 批准号:
    8790798
  • 财政年份:
    2014
  • 资助金额:
    $ 35.7万
  • 项目类别:
Continuation of the Longitudinal Assessment of Bariatric Surgery (LABS) - DCC
减肥手术纵向评估 (LABS) 的延续 - DCC
  • 批准号:
    8011285
  • 财政年份:
    2010
  • 资助金额:
    $ 35.7万
  • 项目类别:

相似海外基金

The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 35.7万
  • 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
  • 批准号:
    10754981
  • 财政年份:
    2023
  • 资助金额:
    $ 35.7万
  • 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
  • 批准号:
    10617997
  • 财政年份:
    2022
  • 资助金额:
    $ 35.7万
  • 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
  • 批准号:
    10538151
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10624966
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10515803
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10258627
  • 财政年份:
    2021
  • 资助金额:
    $ 35.7万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10581505
  • 财政年份:
    2019
  • 资助金额:
    $ 35.7万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10379715
  • 财政年份:
    2019
  • 资助金额:
    $ 35.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了